Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro (Q42458331)

1 November 2017

Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro (English)

1 reference

1 November 2017

1 reference

Kristina Melkersson

1

1 reference

PubMed ID

15013026

1 November 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

European Neuropsychopharmacology

1 November 2017

1 reference

1 November 2017

14

1 reference

1 November 2017

2

1 reference

1 November 2017

115-119

1 reference

DIABETES MELLITUS AS A SIDE EFFECT OF TREATMENT WITH TRICYCLIC NEUROLEPTICS.

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Effects of drugs on glucose and tolbutamide-stimulated insulin release from isolated rat islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Insulin release from human pancreatic islets in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Coated Charcoal Immunoassay of Insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Antipsychotic medication: effects on regulation of glucose and lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Different effects of antipsychotic drugs on insulin release in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Effect of chlorpromazine on insulin release in mice: comparison between in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Differential control of insulin secretion and somatostatin-receptor recruitment in isolated pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

Phenothiazines and Diabetes in Hospitalized Women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

The effect of clozapine on glucose metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900072-5

7 January 2021

10.1016/S0924-977X(03)00072-5

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

15013026